Research
Diabetes: EMA approves the first once-weekly insulin
It is very recent news that the European Medicines Agency (EMA) has approved the world's first weekly insulin for the treatment of adult patients with diabetes. This approach would allow the number of insulin administrations to be reduced to once a week, instead of the current daily administration....
Research
Dengue Fever: controlling and preventing possible outbreaks
It is news in recent days that nearly 2 million "probable cases" of Dengue Fever have been reported in Brazil since the beginning of 2024. The number of possible infections is the highest since 2000 and 4 times the total number of infections reported during the same period in 2023. Ten Brazilian...
Research
For a responsible and prudent use of antimicrobial agents
The World Health Organisation annually celebrates a world awareness week (“World Antimicrobial Awareness Week”) aimed at promoting correct and responsible use of antimicrobials and at increasing awareness of antimicrobial resistance.
Research
Novavax: a new/"old" vaccine against Covid-19
Recently, the announcement of the imminent availability of a new vaccine against COVID-19 has been made: its name isNuvaxovid (NVX-CoV2373) produced by Novavax, an American biotechnology company.
Research
Delivering Covid-19 vaccine, an extraordinary team effort
“We're talking hundreds, probably thousands of people who have been working together to make these [...] systems so that they're actually ready for prime time”. “Everyone just incrementally added something – including me” [1].
Research
mRNA vaccines are safe: here's why
Covid-19 vaccines are among the safest and most effective ever made: they have undergone rigorous studies and strict approval criteria, and their technology is the result of decades of development by researchers around the world.
Research
Covid-19 mRNA vaccines: composition and perspectives
Since the beginning of the SARS-CoV-2 pandemic, the international scientific community has taken action in record time to prepare one or more safe and effective vaccines to prevent infection and the possible clinical evolution in the most serious forms of respiratory disease defined as "COVID-19...
Research
The groundbreaking malaria vaccine for children at risk
October 6, 2021 has been a historic day: WHO gave the final green light to the use of the first vaccine against malaria, one of the deadliest infectious diseases, which causes over 400,000 deaths every year, especially in sub-Saharan Africa. To give an idea of the emergency: a child dies from...
Research
Left-handed life: challenges, myths and curiosities
The world we live in is more designed for right-handed people, i.e. people who preferably use the right hand, while left-handed people are more often faced with uncomfortable inconveniences: from ergonomic scissors to conference chairs with folding tables, from can openers to keyboard shortcuts...
Research
ALS, the motor neuron disease, between research and new therapies
ALS, or amyotrophic lateral sclerosis, is a neurodegenerative disease that selectively affects motor neurons, i.e. the cells of the nervous system that control the movements of our muscles, also known in Italy as "the disease of soccer players", given the unusually high number of athletes who are...